These sessions are designed to highlight the latest advances within each tumour stream, including emerging therapeutics, pivotal studies, and anticipated data.

Presenters have the flexibility to shape their content around what they consider most relevant or impactful within their field. Each session will include a presentation followed by a Q&A or discussion.

At the conclusion of all sessions, presenters will join a panel discussion to explore cross-cutting themes and tumour-specific innovations, drawing connections across the streams presented.

Chairs: Dr Gowri Shivasabesan and Dr Eve Malsem

This session will open with a 15-minute presentation introducing eviQ, Australia’s leading online resource for cancer treatment protocols and clinical information.

Following this, two invited speakers will each share short talks reflecting on their professional journeys and experiences in oncology.

The session will conclude with an informal "Ask Me Anything" panel discussion featuring the speakers and session Chairs. This open Q&A is an opportunity for attendees to ask questions about career pathways, clinical practice, work-life balance, and professional advice.

This special evening will feature a thought-provoking discussion on the evolving role of oral chemotherapy in oncology, presented by two leading experts.

Presentation Topic: Oral Chemotherapy: Advancing Treatment Beyond the Day Unit

Speakers: Dr Niara Oliveira, Medical Oncologist, Mater Hospital, Brisbane and Dr Richard DeBoer, Medical Oncologist, Peter MacCallum Cancer Centre & Epworth Freemasons

Tailored specifically for advanced trainees, this dinner session will explore:

- Evolving practices in personalised medicine

- Challenges surrounding patient adherence

- Key considerations in treatment safety

The evening features a delicious two-course dinner with a beverage package, along with the chance to network and connect with fellow trainee members. Attendance is complimentary for all trainee members.

Join us for an insightful evening with Dr Belinda Yeo, who will present on the key critical advancements in adjuvant care including CDK4/6i, with a focus on the patient selection criteria for high-risk patients and abemaciclib, supported by recent data publications and real world evidence.

Presentation Topic: Evolutions in HR+ HER2- EBC Adjuvant Care: Selecting Patients and Their Treatments

Speaker: Dr Belinda Yeo

The evening features a delicious three-course dinner with a beverage package, along with the chance to network and connect with fellow YOGA members. Attendance is complimentary for all YOGA members.

These sessions are designed to highlight the latest advances within each tumour stream, including emerging therapeutics, pivotal studies, and anticipated data.

Presenters have the flexibility to shape their content around what they consider most relevant or impactful within their field. Each session will include a presentation followed by a Q&A or discussion.

At the conclusion of all sessions, presenters will join a panel discussion to explore cross-cutting themes and tumour-specific innovations, drawing connections across the streams presented.

Chairs: Dr Andrew Parsonson and Dr Elizabeth Connolly

This series of sessions is designed to equip early-career oncologists with practical skills and insights beyond the textbook. From navigating real-world data to managing complex cases, each session offers tools to support confident, well-rounded clinical and research practice.

Ideal for YOGA members and early-career clinicians looking to expand their impact across clinical, academic, and leadership domains.

This special evening will feature a thought-provoking discussion on the evolving role of oral chemotherapy in oncology, presented by two leading experts.

Presentation Topic: Oral Chemotherapy: Advancing Treatment Beyond the Day Unit

Speakers: Dr Niara Oliveira, Medical Oncologist, Mater Hospital, Brisbane and Dr Richard DeBoer, Medical Oncologist, Peter MacCallum Cancer Centre & Epworth Freemasons

Tailored specifically for advanced trainees, this dinner session will explore:

- Evolving practices in personalised medicine

- Challenges surrounding patient adherence

- Key considerations in treatment safety

The evening features a delicious two-course dinner with a beverage package, along with the chance to network and connect with fellow trainee members. Attendance is complimentary for all trainee members.

Join us for an insightful evening with Dr Belinda Yeo, who will present on the key critical advancements in adjuvant care including CDK4/6i, with a focus on the patient selection criteria for high-risk patients and abemaciclib, supported by recent data publications and real world evidence.

Presentation Topic: Evolutions in HR+ HER2- EBC Adjuvant Care: Selecting Patients and Their Treatments

Speaker: Dr Belinda Yeo

The evening features a delicious three-course dinner with a beverage package, along with the chance to network and connect with fellow YOGA members. Attendance is complimentary for all YOGA members.

Chairs: Dr Miles Andrews and Dr Lavinia Spain, ASM Co-Convenors

This session features five rapid presentations introducing key emerging therapies—such as cell therapy, bispecifics, and antibody-drug conjugates—alongside landmark clinical data supporting their use in solid tumours (or haematological malignancies for CAR-T).

Speakers will explain how each modality works, its stage of clinical development, and typical toxicities. The cell therapy segment will also touch on the logistics of delivering or developing these therapies in Australia.

A panel discussion with all speakers and international experts will follow, offering further insights and real-world perspectives.

Chair: A/Prof Rachel Roberts-Thomson

This session opens with a presentation by Dr. Dumbrava on the establishment and workflow of the MD Anderson Brain Metastasis Clinic. A case-based panel discussion will follow, exploring current challenges and best practices in managing brain metastases. Guided by the session chair, panelists will work through two clinical cases, with discussion focused on key decision points in multidisciplinary care.

Panelist: Radiation Oncologist - Dr Joe Sia

Panelist: Medical Oncologist - Dr Mal Ameratunga

Panelist: Neurosurgeon - Prof Lindy Jeffree

Panelist: Regional Medical Oncologist - A/Prof Robert Zielinski

Join us for the Annual Meeting Dinner, MOGA’s signature networking event held at the Pullman Melbourne on the Park. This relaxed evening brings together delegates, speakers, and industry partners to connect over great food and conversation. A key highlight of the ASM program, the dinner offers a valuable opportunity to unwind and build professional relationships.

Chairs: Dr Miles Andrews and Dr Lavinia Spain, ASM Co-Convenors

This session features five rapid presentations introducing key emerging therapies—such as cell therapy, bispecifics, and antibody-drug conjugates—alongside landmark clinical data supporting their use in solid tumours (or haematological malignancies for CAR-T).

Speakers will explain how each modality works, its stage of clinical development, and typical toxicities. The cell therapy segment will also touch on the logistics of delivering or developing these therapies in Australia.

A panel discussion with all speakers and international experts will follow, offering further insights and real-world perspectives.

Chair: A/Prof Rachel Roberts-Thomson

This session opens with a presentation by Dr. Dumbrava on the establishment and workflow of the MD Anderson Brain Metastasis Clinic. A case-based panel discussion will follow, exploring current challenges and best practices in managing brain metastases. Guided by the session chair, panelists will work through two clinical cases, with discussion focused on key decision points in multidisciplinary care.

Panelist: Radiation Oncologist - Dr Joe Sia

Panelist: Medical Oncologist - Dr Mal Ameratunga

Panelist: Neurosurgeon - Prof Lindy Jeffree

Panelist: Regional Medical Oncologist - A/Prof Robert Zielinski

Join us for the Annual Meeting Dinner, MOGA’s signature networking event held at the Pullman Melbourne on the Park. This relaxed evening brings together delegates, speakers, and industry partners to connect over great food and conversation. A key highlight of the ASM program, the dinner offers a valuable opportunity to unwind and build professional relationships.

Chairs: A/Prof Connie Diakos and Dr Udit Nindra

This session features four rapid-fire presentations covering the latest developments in neoadjuvant treatment strategies for head and neck cancer, bladder cancer, melanoma, and cutaneous squamous cell carcinoma. Each speaker will provide a concise overview of the rationale for neoadjuvant therapy in their cancer type, highlighting key clinical trials and emerging data. Where applicable, immunotherapy-based approaches will be emphasised. Each presentation will conclude with a brief Q&A. Attendees will leave with a clear understanding of neoadjuvant treatment principles and current strategies across multiple tumour streams.

Chair: Prof Michael Jefford

Invited speakers will share insights from their experience integrating patient-reported outcomes (PROs) into routine oncology care, highlighting practical challenges and barriers. A consumer representative will also join the session to provide the patient perspective on PRO use in clinical practice.

Chair: Andrew Denton

This session will explore the development and implementation of Voluntary Assisted Dying (VAD) across Australia, covering workforce development, funding models, and ongoing challenges. Short presentations will be followed by a panel discussion on national progress and future directions.

Panel Chair: Andrew Denton

Panellist: Dr Chloe Furst

Panellist: Ms Lesley McLeod

Panellist: Ms Susan Jury

Panellist: Dr Danielle Ferraro

Panellist: Prof Phillip Parente

Patient Panellist: Stephen

Chairs: A/Prof Connie Diakos and Dr Udit Nindra

This session features four rapid-fire presentations covering the latest developments in neoadjuvant treatment strategies for head and neck cancer, bladder cancer, melanoma, and cutaneous squamous cell carcinoma. Each speaker will provide a concise overview of the rationale for neoadjuvant therapy in their cancer type, highlighting key clinical trials and emerging data. Where applicable, immunotherapy-based approaches will be emphasised. Each presentation will conclude with a brief Q&A. Attendees will leave with a clear understanding of neoadjuvant treatment principles and current strategies across multiple tumour streams.

Chair: Prof Michael Jefford

Invited speakers will share insights from their experience integrating patient-reported outcomes (PROs) into routine oncology care, highlighting practical challenges and barriers. A consumer representative will also join the session to provide the patient perspective on PRO use in clinical practice.

Chair: Andrew Denton

This session will explore the development and implementation of Voluntary Assisted Dying (VAD) across Australia, covering workforce development, funding models, and ongoing challenges. Short presentations will be followed by a panel discussion on national progress and future directions.

Panel Chair: Andrew Denton

Panellist: Dr Chloe Furst

Panellist: Ms Lesley McLeod

Panellist: Ms Susan Jury

Panellist: Dr Danielle Ferraro

Panellist: Prof Phillip Parente

Patient Panellist: Stephen